Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Kaynar L.A
1411  Ergebnisse:
Personensuche X
?
1

P1178: THE APPLICABILITY OF PROGNOSTIC MODELS UNDER RITUXIM..:

Vassilakopoulos, Theodoros ; Ferhanoglu, B ; Horowitz, Na...
HemaSphere.  7 (2023)  S3 - p. e2522583 , 2023
Link: https://doi.org/10.1097/..
 
?
2

REAL‐LIFE EXPERIENCE WITH RITUXIMAB‐DOSE‐ADJUSTED EPOCH (R‐..:

Vassilakopoulos, T. ; Ferhanoglu, B. ; Horowitz, N....
Hematological Oncology.  41 (2023)  S2 - p. 410-411 , 2023
Link: https://doi.org/10.1002/..
 
?
3

Evaluation Of Refeeding Hypophosphatemia Frequency, Risk Fa..:

Şahin Ergül, S. ; Güneş Şahin, G. ; Özer, N.T....
Clinical Nutrition ESPEN.  54 (2023)  - p. 507-508 , 2023
Link: https://doi.org/10.1016/..
 
?
4

P1227: POLATUZUMAB VEDOTIN, RITUXIMAB, AND BENDAMUSTINE COM..:

Dal, M. S. ; Uncu Ulu, B. ; Uzay, A....
HemaSphere.  6 (2022)  - p. 1113-1114 , 2022
Link: https://doi.org/10.1097/..
 
?
5

P1229: RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMAR..:

Vassilakopoulos, T. ; Ferhanoglu, B. ; Horowitz, N. A....
HemaSphere.  6 (2022)  - p. 1114-1115 , 2022
Link: https://doi.org/10.1097/..
 
?
6

RITUXIMAB‐DOSE‐ADJUSTED EPOCH (R‐DA‐EPOCH) IN PRIMARY MEDIA..:

Vassilakopoulos, T. ; Ferhanoglu, B. ; Horowitz, N....
Hematological Oncology.  39 (2021)  S2 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
7

Caplacizumab induces fast and durable platelet count respon..:

Kaynar, L. ; Coppo, P. ; Scully, M....
Hematology, Transfusion and Cell Therapy.  42 (2020)  - p. 62-63 , 2020
Link: https://doi.org/10.1016/..
 
?
8

Evaluation of secondary hypogammaglobulinemia in patients w..:

Çelik, S. ; Güven, Z. ; Kaynar, L....
Leukemia Research.  85 (2019)  - p. S39 , 2019
Link: https://doi.org/10.1016/..
 
?
9

Successful treatment of relapsed and refractory cold agglut..:

Çelik, S. ; Güven, Z. ; Eser, B....
Leukemia Research.  85 (2019)  - p. S68-S69 , 2019
Link: https://doi.org/10.1016/..
 
?
10

Infection control bundles in intensive care: an internation..:

Alp, E. ; Cookson, B. ; Erdem, H....
Journal of Hospital Infection.  101 (2019)  3 - p. 248-256 , 2019
Link: https://doi.org/10.1016/..
 
?
11

Risk factors for invasive fungal infection in patients who ..:

Yildizhan, E. ; Varal, F. ; Ciftci, S....
Leukemia Research.  85 (2019)  - p. S60 , 2019
Link: https://doi.org/10.1016/..
 
?
12

Gastrointestinal plasmoblastic lymphoma associated with Wis..:

Ünal, A. ; Çelik, S. ; Güven, Z....
Leukemia Research.  85 (2019)  - p. S45 , 2019
Link: https://doi.org/10.1016/..
 
?
13

Successful Treatment With Granulocyte Transfusion and Early..:

Unal, A. ; Birekul, A. ; Kaynar, L...
Journal of Global Oncology.  4 (2018)  Supplement 2 - p. 225s-225s , 2018
Link: https://doi.org/10.1200/..
 
?
14

The Comparison of Melphalan Administration on Day −3 With A..:

Unal, A. ; Kaynar, L. ; Keni, N....
Journal of Global Oncology.  4 (2018)  Supplement 2 - p. 218s-218s , 2018
Link: https://doi.org/10.1200/..
 
?
15

Nivolumab for relapsed or refractory Hodgkin lymphoma: Expe..:

Ferhanoglu, B. ; Bekoz, H. ; Karadurmus, N....
Hematological Oncology.  35 (2017)  S2 - p. 321-323 , 2017
Link: https://doi.org/10.1002/..
 
1-15